Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zoll's AutoPulse cardiac support:

This article was originally published in Clinica

Executive Summary

Japanese regulators have given Zoll Medical the all-clear to sell its AutoPulse noninvasive cardiac support pump to hospitals and emergency medical services. The product will be sold through the firm's exclusive local distributor, Nihon Kohden, following a five-year agreement between the partners announced earlier this year. Speculating on market prospects, Chelmsford, Massachusetts-based Zoll said that in Japan there are around 9,500 hospitals, 88,000 clinics and 900 fire defence headquarters that provide emergency services. AutoPulse is an automated, portable device with a simple, load-distributing LifeBand that squeezes the entire chest in a consistent, uninterrupted -hands-free" manner, delivering maximum blood flow to the heart and brain.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT053055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel